Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Conjunctival Neoplasms × Ranibizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 6 Retinal Diseases 2 Melanoma 2 Retinoblastoma 1 Neurofibromatosis 1 1 Neurofibroma 1 Macular Edema 1 Macular Degeneration 1 Glaucoma, Neovascular 1 Conjunctival Neoplasms 1 Choroid Diseases 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00456495 2017-07-21

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

The New York Eye Cancer Center

Phase 1 Completed

5 enrolled 6 charts

Conjunctival Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡